openPR Logo
Press release

What's the next big thing in the Oxycodone Market...? Pfizer Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma L.P, Daiichi Sankyo, Acorda Therapeutics, Teikoku Pharma USA, Inc., Mylan N.V

06-27-2019 03:49 PM CET | Health & Medicine

Press release from: Future Market Insights

What's the next big thing in the Oxycodone Market...? Pfizer

Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019. Future Market Insights, in its recent analysis of the global oxycodone market, elaborates on the key market dynamics, opportunity assessment, and regional and competitive landscape analysis, for a period spanning 2018 to 2028.

With nearly 10-fold increase in the use of opioids since its inception, the oxycodone contributes to one of the largest revenue generator in the overall pharmaceutical landscape. Intensifying sales of oxycodone can be attributed to:

Increasing patent expirations for branded products and much lesser new product launches, translating into increased consumption of generics—that contribute to the maximum revenue of the global oxycodone market, thereby, fueling the net sales.

Growing number of cancer treatments, which in turn, increases the demand for supportive care medications for pain management. Increased prescriptions of oxycodone and Hydrocodone for treating cancer pain, will remain the largest contributor to the sales growth of the aforementioned medication.

Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7638

“In terms of demand, high efficiency of synthetic and semi-synthetic opioids increase its use. In addition, Opioids prescription is highly regulated by a set of clinical practice guidelines, while ensuring safe access and proper dosage. Opioids are covered under such stringent regulations translates into increased consumption. Rising awareness about palliative care in terminal disease conditions combined with favorable reimbursement policies are some additional demand-side factors, augmenting the consumption of opioids”, projects a senior analyst at FMI

Elaborating further, the analyst explains that palliative care programs in US—which includes palliative care consultation teams and dedicated in-patient palliative care units—are delivered in accordance with the government and commercial reimbursement policies, further boosting the oxycodone market in the region. In addition to palliative programs, increased prescription in de-addiction programs, is well contributing to the demand of de-addiction opiates.

Innovative Drug Formulations Pushing Oxycodone Global Sales

In the in-depth analysis of the oxycodone market, FMI underlines the introduction of innovative opiate drugs, currently occupying a lion’s share. Innovations in formulations—not necessarily targeted at drug efficacy— is a critical supply-side driver in the global oxycodone market. Abuse-deterrent formulations in Oxycontin, by Purdue Pharma is one such example. Moreover, Purdue has been granted exclusive selling rights for Oxycontin till 2030, after it made formulations changes to the drug’s chemical structure, thereby marketing it as an ‘abuse-proof’, slow-releasing pill. In addition, FDA’s nod to new generation drugs, making them ‘less-addictive’, will gain prominence through 2028. Drug advancements in extended-release medications for pain control, would supplement to the sales of oxycodone, globally. This scenario is expected to create favorable adoption opportunities for long-standing oxycodone, notes FMI in its report titled “Oxycodone Market Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028”.

Download Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-7638

Opportunity Analysis of Oxycodone Market Reveals Lucrative Growth Prospects

In terms of business expansion opportunities, strategic investments, licensing agreements, and acquisitions hold significant potential.

Apart from the above mentioned, investments in research and development activities would present potential growth opportunities for oxycodone manufacturers.

Increasing strategic collaborations between manufacturers and generic drugs distributors operating in the pain management business, will prove critical to forward expansion plans.

As demand for oxycodone remains uniform across patients of all age groups, opioids are expected to offer effective drug formulations and enhanced solubility of API, further prompting manufactures to capitalize on the emerging latent opportunity.

Rising prevalence of chronic diseases in humans and increasing demand for parenteral formulations around the world, particularly in North American countries, will supplement to the growth of oxycodone market in the region.

Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Website: https:www.futuremarketinsights.com

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's the next big thing in the Oxycodone Market...? Pfizer Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma L.P, Daiichi Sankyo, Acorda Therapeutics, Teikoku Pharma USA, Inc., Mylan N.V here

News-ID: 1790521 • Views:

More Releases from Future Market Insights

Robotic Vision Market Set to Reach USD 7.9 Billion by 2035 as Established and Emerging Manufacturers Drive Innovation
Robotic Vision Market Set to Reach USD 7.9 Billion by 2035 as Established and Em …
The robotic vision market is entering an extraordinary phase of growth, fueled by rapid advancements in automation and artificial intelligence. According to the latest forecast, the industry is expected to be valued at USD 3.2 billion in 2025 and will nearly triple to USD 7.9 billion by 2035, registering a CAGR of 9.5% during the forecast period. This growth underscores the increasing reliance on intelligent vision systems to enhance manufacturing
Decision Management Applications Market to Surpass USD 1.7 Billion by 2035 as Established Leaders and Emerging Innovators Redefine Intelligent Decisioning
Decision Management Applications Market to Surpass USD 1.7 Billion by 2035 as Es …
The global decision management applications market is entering a transformative decade. Valued at USD 928.0 million in 2025, the sector is projected to nearly double, reaching USD 1,742.0 million by 2035, growing at a steady CAGR of 6.5%. This growth is being driven by enterprises seeking faster, smarter, and more accurate decisions in an increasingly complex business landscape. Established players such as IBM Corporation, SAS Institute Inc., and Salesforce.com, Inc.
Integrated UPS Market Poised to Reach USD 21.3 Billion by 2035 as Power Reliability Becomes a Global Priority
Integrated UPS Market Poised to Reach USD 21.3 Billion by 2035 as Power Reliabil …
The global market for integrated uninterruptible power supply (UPS) systems is entering a new growth phase as industries worldwide intensify their focus on uninterrupted operations and digital resilience. According to recent forecasts, the integrated UPS market will rise from an estimated USD 13.1 billion in 2025 to USD 21.3 billion by 2035, recording a compound annual growth rate (CAGR) of 5.0%. This growth reflects both the critical role of power
Tablet Based E-Detailing Market Set to Reach USD 67.5 Billion by 2035 as Pharma Giants and Innovators Drive Digital Engagement
Tablet Based E-Detailing Market Set to Reach USD 67.5 Billion by 2035 as Pharma …
The global tablet based e-detailing market is entering a period of steady expansion, with its value expected to grow from USD 47.4 billion in 2025 to USD 67.5 billion by 2035. Registering a compound annual growth rate (CAGR) of 3.6%, the market is being shaped by a fundamental shift in how life sciences and healthcare companies engage with physicians. The transition from traditional in-person detailing to digital-first approaches reflects both

All 5 Releases


More Releases for Oxycodone

Oxycodone Drugs Top Companies Data Analysis to 2031
The Oxycodone Drugs Market is expected to register a CAGR of 5.4% from 2025 to 2031. The report is segmented By Product (Short-acting, and Long-acting), Application (Pain Management, and De-addiction), Distribution Channel (Hospital Pharmacies, and Retail Pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments. Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00040896/?utm_source=OpenPR&utm_medium=10413 The List of Companies Teva Pharmaceutical
Orthopedic Disorder Surge Fuels Oxycodone Market Growth: A Significant Driver Pr …
The Oxycodone Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Oxycodone Drugs Market Size and Projected Growth Rate? The oxycodone drugs market has experienced strong growth over the years. It is forecasted to rise from $5.62 billion in 2024 to $6.04 billion
Oxycodone Market is Booming Worldwide | Pfizer, Apotex, Mylan
The Latest Released Oxycodone market study has evaluated the future growth potential of Global Oxycodone market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities,
Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driver: Leading Transfor …
What market dynamics are playing a key role in accelerating the growth of the oxycodone drugs market? The high prevalence of orthopedic disorders is projected to drive the oxycodone drug market. These disorders, which affect the bones, joints, muscles, and soft tissues, cause significant pain and impair mobility. Oxycodone drugs are commonly used to manage acute and chronic pain related to orthopedic conditions. The Institute for Health Metrics and Evaluation (IHME)
Key Oxycodone Drugs Market Trend for 2025-2034: Focus On Developing Immediate-Re …
What Is the Future Outlook for the Oxycodone Drugs Market's Size and Growth Rate? The market for oxycodone drugs has experienced robust growth in the past few years. The size of the market is projected to escalate from $5.62 billion in 2024 to $6.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The historical period's growth is mainly due to an intensive marketing strategy for OxyContin.
Oxycodone Hydrochloride Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Oxycodone Hydrochloride Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. Oxycodone Hydrochloride Market Size And Scope The Oxycodone Hydrochloride market is characterized by steady demand, driven by its use as a prescription opioid analgesic for moderate